Case Study: Several stakeholders have engaged the services of CMOs to cater to the complexities related to manufacturing and assembly of large volume wearable injectors

Rising complexities related to handling and administration of novel / advanced therapeutic options, have caused many device developers to outsource certain aspects of their businesses…

View More Case Study: Several stakeholders have engaged the services of CMOs to cater to the complexities related to manufacturing and assembly of large volume wearable injectors

Close to 200 Marketed and Pipeline drugs have the potential to be formulated for delivery via the Large Volume Wearable Injectors

To meet the increasing demand for patient-friendly and safe options for drug administration, the drug developers are expected to broader their portfolio of drug candidates…

View More Close to 200 Marketed and Pipeline drugs have the potential to be formulated for delivery via the Large Volume Wearable Injectors

Status of Patents that have been Filed / Granted in the Large Volume Wearable Injectors Domain related to Pharmaceutical and Biopharmaceutical Industry

With the increase in popularity of self-injection devices, several industry stakeholders have attempted to innovate the devices by incorporating advanced features to improve patient compliance…

View More Status of Patents that have been Filed / Granted in the Large Volume Wearable Injectors Domain related to Pharmaceutical and Biopharmaceutical Industry

The Increasing Traction in the Field of Large Volume Wearable Injectors is Reflected in the Partnership Activity Focused on the delivery of both insulin and non-insulin drugs, Involving Stakeholders across the world

Stakeholders in the pharmaceutical and medical-device development industry are known to adopt a variety of partnership models to collaborate with other companies / organizations. Such…

View More The Increasing Traction in the Field of Large Volume Wearable Injectors is Reflected in the Partnership Activity Focused on the delivery of both insulin and non-insulin drugs, Involving Stakeholders across the world
Top